| RS1569845887 |
PLEKHG5
|
Health Risk |
Likely pathogenic |
— |
| RS1569848362 |
PLA2G5
|
Health Risk |
Pathogenic |
Late-onset retinal degeneration, Late-onset retinal degeneration |
| RS1569851570 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1569853976 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1569854012 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1569854342 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1569854381 |
MFN2
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2A2 |
| RS1569861708 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease |
| RS1569862384 |
MFN2
|
Health Risk |
Likely pathogenic |
— |
| RS1569865516 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1569868729 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1569871830 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2 |
| RS1569875704 |
PLEKHG5
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease recessive intermediate C, Neuronopathy |
| RS1569882539 |
MFN2
|
Health Risk |
Pathogenic |
Charcot-Marie-Tooth disease type 2, Charcot-Marie-Tooth disease type 2 |
| RS1569889919 |
MFN2
|
Health Risk |
Pathogenic/Likely pathogenic |
Charcot-Marie-Tooth disease, Charcot-Marie-Tooth disease type 2A2 |
| RS1569960119 |
UROD
|
Health Risk |
Likely pathogenic |
— |
| RS1569967143 |
UROD
|
Health Risk |
Pathogenic |
Familial porphyria cutanea tarda, Familial porphyria cutanea tarda |
| RS1569967422 |
LCK
|
Health Risk |
Likely pathogenic |
Severe combined immunodeficiency due to LCK deficiency, Severe combined immunodeficiency due to LCK deficiency |
| RS1570008399 |
ADPRS
|
Health Risk |
Likely pathogenic |
Neurodegeneration, childhood-onset |
| RS1570012058 |
ADPRS
|
Health Risk |
Likely pathogenic |
Neurodegeneration, childhood-onset |
| RS1570013257 |
ADPRS
|
Health Risk |
Likely pathogenic |
Neurodegeneration, childhood-onset |
| RS1570018597 |
PRDM2
|
Health Risk |
Likely pathogenic |
Flexion contracture, Flexion contracture |
| RS1570024112 |
CDC42
|
Health Risk |
Likely pathogenic |
Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome, Macrothrombocytopenia-lymphedema-developmental delay-facial dysmorphism-camptodactyly syndrome |
| RS1570073403 |
C1QA
|
Health Risk |
Likely pathogenic |
C1Q deficiency 1, C1Q deficiency |
| RS1570098248 |
PAX7
|
Health Risk |
Pathogenic |
Myopathy, congenital |
| RS1570099690 |
RSPO1
|
Health Risk |
Pathogenic |
Palmoplantar hyperkeratosis and true hermaphroditism, Palmoplantar hyperkeratosis and true hermaphroditism |
| RS1570108068 |
STIL
|
Health Risk |
Likely pathogenic |
— |
| RS1570122721 |
NFIA
|
Health Risk |
Likely pathogenic |
— |
| RS1570123287 |
NFIA
|
Health Risk |
Likely pathogenic |
Chromosome 1p32-p31 deletion syndrome, Chromosome 1p32-p31 deletion syndrome |
| RS1570186429 |
AK2
|
Health Risk |
Likely pathogenic |
Reticular dysgenesis, Reticular dysgenesis |
| RS1570190059 |
AGRN
|
Health Risk |
Pathogenic/Likely pathogenic |
Congenital myasthenic syndrome, Congenital myasthenic syndrome 8 |
| RS1570193864 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1570195582 |
AGRN
|
Health Risk |
Pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1570238098 |
MFSD2A
|
Health Risk |
Pathogenic |
8 conditions, 8 conditions |
| RS1570242061 |
AGRN
|
Health Risk |
Likely pathogenic |
Congenital myasthenic syndrome 8, Congenital myasthenic syndrome 8 |
| RS1570273880 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypophosphatasia, Hypophosphatasia |
| RS1570276523 |
ALPL
|
Health Risk |
Likely pathogenic |
— |
| RS1570301527 |
PCSK9
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypercholesterolemia, autosomal dominant |
| RS1570309482 |
ALPL
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1570312139 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570312735 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570312788 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570319915 |
ATAD3A
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia, hypotonia |
| RS1570332505 |
DHDDS
|
Health Risk |
Pathogenic/Likely pathogenic |
Developmental delay and seizures with or without movement abnormalities, Inborn genetic diseases |
| RS1570334344 |
CLCNKB
|
Health Risk |
Pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS1570340095 |
CLCNKB
|
Health Risk |
Likely pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS1570341086 |
CLCNKB
|
Health Risk |
Pathogenic |
Bartter disease type 3, Bartter disease type 3 |
| RS1570345942 |
ATAD3A
|
Health Risk |
Pathogenic |
Congenital cerebellar hypoplasia, Pontocerebellar hypoplasia |
| RS1570346203 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570346782 |
MUTYH
|
Health Risk |
Likely pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570362086 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570363119 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570364144 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570366181 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570367144 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1570367230 |
ABCA4
|
Health Risk |
Pathogenic |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1570367367 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Severe early-childhood-onset retinal dystrophy, Severe early-childhood-onset retinal dystrophy |
| RS1570367398 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
Cone-rod dystrophy, Retinal dystrophy |
| RS1570370748 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570370826 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1570370929 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1570373385 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570373408 |
ABCA4
|
Health Risk |
Pathogenic |
Cone-rod dystrophy 3, Retinal dystrophy |
| RS1570373782 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570376147 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Familial adenomatous polyposis 2 |
| RS1570377836 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1570377861 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Retinal dystrophy |
| RS1570380080 |
ABCA4
|
Health Risk |
Likely pathogenic |
Stargardt disease, Stargardt disease |
| RS1570381679 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570382663 |
ABCA4
|
Health Risk |
Likely pathogenic |
Retinitis pigmentosa, Cone-rod dystrophy 3 |
| RS1570382710 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570382822 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570385510 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570386206 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1570386293 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570387558 |
ABCA4
|
Health Risk |
Likely pathogenic |
— |
| RS1570388553 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570392557 |
ABCA4
|
Health Risk |
Pathogenic |
— |
| RS1570393727 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1570393848 |
ABCA4
|
Health Risk |
Likely pathogenic |
Cone-rod dystrophy 3, Cone-rod dystrophy 3 |
| RS1570394071 |
ABCA4
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1570395209 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570396086 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570401055 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570402446 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570403798 |
EPHA2
|
Health Risk |
Likely pathogenic |
Cataract 6 multiple types, Cataract 6 multiple types |
| RS1570404090 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570406175 |
FOXE3
|
Health Risk |
Pathogenic |
Congenital primary aphakia, Congenital primary aphakia |
| RS1570406302 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Gastric cancer |
| RS1570406957 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570407032 |
ABCA4
|
Health Risk |
Pathogenic |
Stargardt disease, Stargardt disease |
| RS1570407081 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570407749 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570408704 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570409378 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS1570409596 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570409700 |
MUTYH
|
Health Risk |
Likely pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1570415363 |
MUTYH
|
Health Risk |
Pathogenic |
Familial adenomatous polyposis 2, Hereditary cancer-predisposing syndrome |
| RS1570423722 |
MUTYH
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |
| RS1570423912 |
MUTYH
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Familial adenomatous polyposis 2 |